Basic Info.
Classification
Biochemical Apparatus
Type
Automatic Nucleic Acid Extraction Equipment
Transport Package
Wooden Carton
Specification
775mm*615mm*500mm
Product Description
Detailed Photos
Product Description
SAMPLE FLUX | 96 Samples |
SAMPLE SIZE | 20-1000uL |
EXTRACTION SPEED | Automatic sample addition mode 96T/25min,Full-process automatic mode 96T/35min |
MAGNETIC BEAD RECOVERY METHOD | > 98% |
NUMBER OF MAGNETS | 96 rods |
POWER SUPPLY | AC 100-240V, 50/60HZ |
WEIGHT | 80KG |
VOLUME | 775mm*615mm*500mm |
Company Profile
Founded in 2003, Jinan Baibo is a high-tech enterprise specializing in the development, production and sales of in vitro diagnostic reagents.The company was successfully listed on the New Third Board on May 30, 2014 (securities name: Baibo Biological, stock code: 830774), becoming the first domestic in vitro diagnostic reagent listed company after the expansion of the New Third Board.The company has established a strict quality management system and passed ISO9001: 2015 and ISO13485: 2016 international quality system certifications. It has advanced international fully automatic production equipment, and the workshop is designed in strict accordance with standards and has reached 10,000-level purification standards. Baibo has strong biotechnology power, and currently has more than 60 independent intellectual property rights, including 2 invention patents, and undertakes many provincial and municipal science and technology innovation projects.The products are mainly related to microorganisms / clinical reagents, medical equipment / robots, biochemical diagnostic reagents and so on.Baibo's corporate purpose is to care for human health, develop a magnificent career in medical technology, and achieve a successful life. Guided by the ingenious product concept of pursuing perfection, the company is committed to providing disposable medical microbial culture media.The company continuously improves technology and develops new products according to market needs, and makes every effort to meet customer needs.
FAQ
1. who are we?
We are based in Shandong, China, start from 2003,sell to North America(40.00%),Mid East(20.00%),Western Europe(20.00%),Domestic Market(13.00%),Southern Europe(3.00%),Southeast Asia(00.00%),Africa(00.00%),Northern Europe(00.00%),South Asia(00.00%). There are total about 51-100 people in our office.
2. how can we guarantee quality?
Always a pre-production sample before mass production;
Always final Inspection before shipment;
3.what can you buy from us?
Transport Medium/Microbial Medium/Pet Disease Detection Kit/Clinical Rapid Detection Kit/Microbial Sample Pretreatment System
4. why should you buy from us not from other suppliers?
The company has passed the international quality system certification.These17 years of R & D design experience have helped us obtain more than 60 intellectual property rights.The company's product market share is also increasing year by year.
5. what services can we provide?
Accepted Delivery Terms: FOB,CFR,CIF,EXW,FAS,CIP,FCA,CPT,DEQ,DDP,DDU,Express Delivery,DAF,DES;
Accepted Payment Currency:USD,EUR,JPY,CAD,AUD,HKD,GBP,CNY,CHF;
Accepted Payment Type: T/T,L/C,D/P D/A,MoneyGram,Credit Card,PayPal,Western Union,Cash,Escrow;
Language Spoken:English,Chinese,Spanish,Japanese,German,Arabic,French,Russian,Korean,Italian
Address:
No. 1777, Dazheng Road, High-Tech Zone, Jinan City, Shandong Province
Business Type:
Manufacturer/Factory
Business Range:
Health & Medicine
Management System Certification:
ISO 9001, ISO 13485
Company Introduction:
Inan Babio Biotechnology Co., Ltd. Was established in 2003. It is a professional high-tech enterprise focusing on the research and development, production and sales of in vitro diagnostic reagents. The company was successfully listed on the New Third Board in 2014 (stock name: Baibo Bio, stock code: 830774). The company has established a strict quality management system and has passed ISO9001: 2008 and ISO13485: 2003 international quality system certification. The company has international advanced automated production equipment and pharmaceutical-grade standard purification workshops. At present, it has more than 72 independent intellectual property rights, Undertook a number of national-level scientific research projects, and has 91 medical device registration certificates approved by the State Food and Drug Administration. The company′s products mainly involve virus sampling, sterile swabs, rapid detection kits, microbial detection reagents, POCT detection reagents, biochemical diagnostic reagents, diagnostic equipment such as pregnancy test products, etc. When the global epidemic broke out in 2020, Babio was actively involved in the research and development and manufacturing of sampling and testing reagents. At present, the company′s viral vectors, nasal/oral sampling swabs and rapid The test kits have been sold to more than 56 countries. The quality of the products has been recognized by medical institutions and laboratories in various countries. The company has made contributions to the global people′s fight against the epidemic. In the future, Baibo Bio will continue to work hard to help the global epidemic prevention and control. Make a new contribution!